کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4285578 | 1611963 | 2016 | 6 صفحه PDF | دانلود رایگان |
• We performed a meta-analysis based on 8 eligible articles for the risk of renal cancer in liver transplant recipient. These studies were based on several developed countries, which included USA, UK, Finland, Sweden, German, Canada, Japan, Netherlands.
• We also performed sensitivity analyses and publication bias analyses.
• This meta-analysis showed a significantly increased risk of developing renal cancer in LTRs.
Liver transplantation is associated with a significantly increased risk of de novo malignancies, but for renal cancer this risk is less clear. We therefore performed a meta-analysis of published studies to determine whether renal cancer risk in liver transplant recipients (LTRs) was increased. To obtain a more precise conclusion, a systematic search was performed in PubMed and Web of Science databases until June 10, 2015. Standardized incidence ratio (SIR) corresponding 95% confidence interval (CI) were used to estimate risk of renal cancer in LTRs. Heterogeneity test, sensitivity analysis, and publishing bias were also performed. We identified 8 eligible studies and performed a meta-analysis on data of 49,654 LTRs with a total follow-up of 121,514.6 patient-years. The SIR for renal cancer was identified a 3.275-fold higher SIR (95% CI: 1.857–5.777; P < 0.001) in LTRs compared with the general population. This systematic review and meta-analysis demonstrated that the LTRs was associated with a significant increase in the incidence of renal cancer. Such association suggests that yearly routine post-transplant surveillance is need for renal cancer in LTRs.
Journal: International Journal of Surgery - Volume 25, January 2016, Pages 128–133